Santalis Pharmaceuticals, Inc.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- -
- Market Cap
- -
A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis
Phase 2
Completed
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: SAN021 PlaceboDrug: SAN021 Serum
- First Posted Date
- 2016-12-22
- Last Posted Date
- 2019-05-29
- Lead Sponsor
- Santalis Pharmaceuticals, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT03000608
- Locations
- ๐บ๐ธ
DermResearch, Inc., Austin, Texas, United States
๐บ๐ธProgressive Clinical Research, San Antonio, Texas, United States
๐บ๐ธClinical Trial of Texas, San Antonio, Texas, United States
A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
Phase 2
Withdrawn
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: PlaceboDrug: SAN007 Cream
- First Posted Date
- 2016-12-22
- Last Posted Date
- 2019-01-17
- Lead Sponsor
- Santalis Pharmaceuticals, Inc.
- Registration Number
- NCT03000595
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults
Phase 2
Withdrawn
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: SAN021 SerumDrug: SAN021 Placebo
- First Posted Date
- 2016-12-15
- Last Posted Date
- 2019-01-17
- Lead Sponsor
- Santalis Pharmaceuticals, Inc.
- Registration Number
- NCT02993328
- Locations
- ๐ฆ๐บ
Dermatology West, Fremantle, Western Australia, Australia
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
Phase 2
Completed
- Conditions
- Atopic DermatitisEczema
- Interventions
- Drug: PlaceboDrug: SAN007 10% creamDrug: SAN007 5% cream
- First Posted Date
- 2016-08-18
- Last Posted Date
- 2019-05-29
- Lead Sponsor
- Santalis Pharmaceuticals, Inc.
- Target Recruit Count
- 71
- Registration Number
- NCT02871479
- Locations
- ๐บ๐ธ
DermResearch, Austin, Texas, United States
๐บ๐ธJ&S Sudies Pharmaceutical, Bryan, Texas, United States
๐บ๐ธProgressive Clinical Research, San Antonio, Texas, United States
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Oral Mucositis
Phase 2
Completed
- Conditions
- Oral Mucositis
- Interventions
- Drug: 0.25% EISO mouth rinse
- First Posted Date
- 2015-03-26
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- Santalis Pharmaceuticals, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT02399228
- Locations
- ๐บ๐ธ
UTHSCSA Cancer Therapy and Research Center (CTRC), San Antonio, Texas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath